- Home
- NSA vs PTGX Comparison
NSA vs PTGX Comparison
Compare NSA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- PTGX
- Stock Information
- Founded
- NSA 2013
- PTGX 2006
- Country
- NSA United States
- PTGX United States
- Employees
- NSA N/A
- PTGX N/A
- Industry
- NSA Real Estate Investment Trusts
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- PTGX Health Care
- Exchange
- NSA Nasdaq
- PTGX Nasdaq
- Market Cap
- NSA 3.4B
- PTGX 2.8B
- IPO Year
- NSA 2015
- PTGX 2016
- Fundamental
- Price
- NSA $44.18
- PTGX $41.65
- Analyst Decision
- NSA Hold
- PTGX Strong Buy
- Analyst Count
- NSA 9
- PTGX 7
- Target Price
- NSA $43.31
- PTGX $53.57
- AVG Volume (30 Days)
- NSA 469.1K
- PTGX 700.6K
- Earning Date
- NSA 10-30-2024
- PTGX 11-07-2024
- Dividend Yield
- NSA 5.01%
- PTGX N/A
- EPS Growth
- NSA 71.81
- PTGX N/A
- EPS
- NSA 1.83
- PTGX 2.68
- Revenue
- NSA $786,922,000.00
- PTGX $323,795,000.00
- Revenue This Year
- NSA N/A
- PTGX $396.93
- Revenue Next Year
- NSA $1.63
- PTGX N/A
- P/E Ratio
- NSA $24.46
- PTGX $15.15
- Revenue Growth
- NSA N/A
- PTGX 125.73
- 52 Week Low
- NSA $32.42
- PTGX $16.80
- 52 Week High
- NSA $49.44
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- NSA 54.29
- PTGX 41.01
- Support Level
- NSA $43.11
- PTGX $33.31
- Resistance Level
- NSA $44.26
- PTGX $48.86
- Average True Range (ATR)
- NSA 1.07
- PTGX 2.82
- MACD
- NSA 0.28
- PTGX -0.62
- Stochastic Oscillator
- NSA 82.97
- PTGX 53.63
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, Northwest and Move It brands.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.